SEC FORM 3/A

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Vinay Monica P.

(Last)

(First)

(Middle)

1293 SOUTH MAIN STREET

(Street)

AKRON

44301

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
07/01/2022

3. Issuer Name and Ticker or Trading Symbol
MYERS INDUSTRIES INC [ MYE ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Interim CFO, VP and Treasurer

5. If Amendment, Date of Original Filed (Month/Day/Year)
08/11/2022

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	13,865⁽¹⁾	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Options	⁽²⁾	03/01/2023	Common Stock	2,100	$14.77	D
Stock Options	⁽³⁾	03/07/2024	Common Stock	3,100	$20.93	D
Stock Options	⁽⁴⁾	03/05/2025	Common Stock	3,200	$18.69	D
Stock Options	⁽⁵⁾	03/02/2026	Common Stock	6,100	$11.62	D
Stock Options	⁽⁶⁾	03/02/2027	Common Stock	11,317	$14.3	D
Stock Options	⁽⁷⁾	03/08/2028	Common Stock	7,031	$21.3	D
Stock Options	⁽⁸⁾	03/06/2029	Common Stock	7,095	$18.58	D
Restricted Stock Units	⁽⁹⁾	⁽⁹⁾	Common Stock	1,644	⁽¹⁰⁾	D
Restricted Stock Units	⁽¹¹⁾	⁽¹¹⁾	Common Stock	1,943	⁽¹⁰⁾	D
Restricted Stock Units	⁽¹²⁾	⁽¹²⁾	Common Stock	3,239	⁽¹⁰⁾	D
Performance Stock Units	⁽¹³⁾	03/15/2023	Common Stock	7,398	⁽¹³⁾	D
Performance Stock Units	⁽¹⁴⁾	03/16/2024	Common Stock	4,370	⁽¹⁴⁾	D
Performance Stock Units	⁽¹⁵⁾	03/16/2025	Common Stock	4,858	⁽¹⁵⁾	D

Explanation of Responses:

1. The Form 3 initially filed by the reporting person incorrectly reported that the reporting person directly owned 23,162 shares of common stock. There are no other changes to the initial Form 3 filed by the reporting person.

2. On March 1, 2013, the Issuer granted the reporting person options vesting in three equal annual installments beginning on the first anniversary of the grant date. The options became fully exercisable on March 1, 2016.

3. On March 7, 2014, the Issuer granted the reporting person options vesting in three equal annual installments beginning on the first anniversary of the grant date. The options became fully exercisable on March 7, 2017.

4. On March 5, 2015, the Issuer granted the reporting person options vesting in three equal annual installments beginning on the first anniversary of the grant date. The options became fully exercisable on March 5, 2018.

5. On March 2, 2016, the Issuer granted the reporting person options vesting in three equal annual installments beginning on the first anniversary of the grant date. The options became fully exercisable on March 2, 2019.

6. On March 2, 2017, the Issuer granted the reporting person options vesting in three equal annual installments beginning on the first anniversary of the grant date. The options became fully exercisable on March 2, 2020.

7. On March 8, 2018, the Issuer granted the reporting person options vesting in three equal annual installments beginning on the first anniversary of the grant date. The options became fully exercisable on March 8, 2021.

8. On March 6, 2019, the Issuer granted the reporting person options vesting in three equal annual installments beginning on the first anniversary of the grant date. The options became fully exercisable on March 6, 2022.

9. On April 28, 2020, the Issuer granted the reporting person 4,932 restricted stock units. 3,288 restricted stock units vested in two equal annual installments on March 6, 2021 and March 6, 2022. The remaining restricted stock units will vest on March 6, 2023.

10. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

11. On March 16, 2021, the Issuer granted the reporting person 2,914 restricted stock units. 971 restricted stock units vested on March 16, 2022. The remaining restricted stock units will vest in two equal annual installments on March 16, 2023 and March 16, 2024.

12. On March 15, 2022, the Issuer granted the reporting person 3,239 restricted stock units, vesting in three equal annual installments on March 16, 2023, March 16, 2024, and March 16, 2025.

13. Each performance share represents a contingent right to receive one share of the Issuer's Common Stock based upon the Issuer's adjusted EBITDA (50%) and ROIC (50%) over a three-year performance period ending December 31, 2022.

14. Each performance stock unit represents a contingent right to receive one share of the Issuer's Common Stock based upon the Issuer's cumulative adjusted EBITDA with a relative TSR modifier over a three-year performance period ending December 31, 2023.

15. Each performance stock unit represents a contingent right to receive one share of the Issuer's Common Stock based upon the Issuer's cumulative adjusted EBITDA with a relative TSR modifier over a three-year performance period ending December 31, 2024.

Remarks:

	/s/ J. Bret Treier, attorney in fact for Monica P. Vinay	02/27/2023
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.